Bullous lichen sclerosus–generalized morphea overlap syndrome improved by tofacitinib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bullous lichen sclerosus–generalized morphea overlap syndrome improved by tofacitinib

Published:2022-11-03 Issue:12 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Liu Licong¹²,Zhan Yi¹²^ORCID,Shi Yaqian¹²,Zeng Zhuotong¹²,Yu Jiangfan¹²,Zou Puyu¹²,Qiu Xiangning¹²,Zhou Ying¹²,Zhang Guiying¹²,Ding Yan³⁴,Xiao Rong¹²

Affiliation:

1. Department of Dermatology Second Xiangya Hospital of Central South University Changsha China

2. Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province Changsha China

3. Department of Dermatology Hainan Provincial Hospital of Skin Disease Haikou China

4. Department of Dermatology Affiliated Dermatology Hospital of Hainan Medical College Haikou China

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15942

Reference14 articles.

1. Extragenital bullous lichen sclerosus

2. German guidelines for the diagnosis and therapy of localized scleroderma

3. Coexistence of lichen sclerosus and morphea: A retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center

4. The anti‐fibrotic effect of cold atmospheric plasma on localized scleroderma In vitro and In vivo;Arndt S;Biomedicine,2021

5. Clinical significance of Janus Kinase inhibitor selectivity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphoea and Allied Scarring and Sclerosing Inflammatory Dermatoses;Rook's Textbook of Dermatology;2024-03-19

2. Tofacitinib for the treatment of severe rare skin diseases: a narrative review;European Journal of Clinical Pharmacology;2024-01-17

3. Quoi de neuf en thérapeutique dermatologique ?;Annales de Dermatologie et de Vénéréologie - FMC;2023-12

4. Multiple drugs;Reactions Weekly;2023-03-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3